Table 2.
Characteristics of interventions and their effect.
| Study | Description of the study group | Intervention effect | |
|
|
Intervention group | Control group |
|
| Dong et al [28], 2016 |
|
|
Weight: +a (IGb), BMI: + (IG, CGc), ACd: + (IG), ALTe: + (IG), ASTf: −g, NAFLD-FSh: + (IG, CG), liver steatosis grade: + (IG, CG) |
| Fard et al [29], 2016 |
|
|
Weight: + (IG), BMI: + (IG), ALT: + (IG), AST: + (IG) |
| Axley et al [27], 2017 |
|
|
Weight: + (IG), BMI: + (IG), ALT: + (IG), AST: + (IG), HDLi: −, TGj: + (IG) |
| Lim et al [30], 2020 |
|
|
Weight: + (IG), BMI: + (IG), Waist circumference: + (IG, CG), ALT: + (IG), AST: + (IG) |
| Mazzotti et al [31], 2018 |
|
|
Weight: + (IG), 10% weight loss: −, Waist circumference: + (IG), GGTk: + (IG), ALT: + (IG) |
| Pfirrmann et al [25], 2019 |
|
|
Weight: +, body fat: + |
| Tincopa et al [32] |
|
|
Weight: −, BMI: −, Liver fat: −, Waist circumference: +, HDL: +, LDL: +, TG: +, HbA1cl: + |
a+: yes.
bIG: intervention group.
cCG: control group.
dAC: abdominal circumference.
eALT: alanine aminotransferase.
fAST: aspartate aminotransferase.
g–: no.
hNAFLD-FS: nonalcoholic fatty liver disease fibrosis score.
iHDL: high-density lipoprotein.
jTG: triglyceride.
kGGT: gamma-glutamyl transferase.
lHbA1c: hemoglobin A1c.